31 October 2016 - Deborah Wilkes
Archived
Bayer's Consumer Health business achieved "moderate sales growth" in the third quarter of 2016, but reported a decrease in its Earnings Before Interest, Taxation, Depreciation and Amortisation (EBITDA) before special items.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.